Molecular docking has emerged as an indispensable tool in the development of antimicrobial compounds, enabling researchers to predict the binding interactions between small molecules and specific ...

When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that ...

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...